Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-13T05:20:19.077Z Has data issue: false hasContentIssue false
  • English
  • Français

COX 2 selectivity of non-steroidal anti-inflammatory drugs and perioperative blood loss in hip surgery. A randomized comparison of indomethacin and meloxicam

Published online by Cambridge University Press:  11 July 2005

E. W. G. Weber ,
R. Slappendel ,
M. E. Durieux ,
R. Dirksen ,
H. van der Heide  and
M. Spruit
E. W. G. Weber
Affiliation:
University Hospital Maastricht, Department of Anesthesiology, Maastricht, The Netherlands
R. Slappendel
Affiliation:
Maartenskliniek, Nijmegen, The Netherlands
M. E. Durieux
Affiliation:
University Hospital Maastricht, Department of Anesthesiology, Maastricht, The Netherlands
R. Dirksen
Affiliation:
Maartenskliniek, Nijmegen, The Netherlands
H. van der Heide
Affiliation:
Maartenskliniek, Nijmegen, The Netherlands
M. Spruit
Affiliation:
Maartenskliniek, Nijmegen, The Netherlands
Get access

Extract

Summary

Background: In this prospective randomized study we tested the hypothesis that use of more cyclo-oxygenase 2 (COX 2)-selective non-steroidal anti-inflammatory drugs (NSAIDs) can reduce perioperative blood loss compared with non-selective NSAIDs.

Methods: Data from 200 patients who underwent total hip replacement were studied. Two NSAIDs were compared: indomethacin 50 mg (n = 82) and meloxicam 15 mg (n = 86). Both NSAIDs were given orally 1 h before surgery.

Results: The two groups were not different with respect to age, gender, ASA class or duration of surgery. When indomethacin was used preoperatively, intraoperative blood loss was 623 ± 243 mL (mean ± SD) and postoperative blood loss 410 ± 340 mL. After meloxicam, these values were 524 ± 304 mL and 358 ± 272 mL, respectively. Total perioperative blood loss after meloxicam was 17% (P < 0.05) less than that observed after indomethacin.

Conclusion: Perioperative blood loss after meloxicam is less than after indomethacin. These in vivo findings are consistent with in vitro results using selective COX 2 NSAIDs.

Keywords

ANALGESICS, NON-NARCOTIC, anti-inflammatory agents, non-steroidalARTHROPLASTY, REPLACEMENT, HIPHAEMORRHAGE, blood loss, surgical
Type
Original Article
Information
European Journal of Anaesthesiology , Volume 20 , Issue 12 , December 2003 , pp. 963 - 966
Copyright
© 2003 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Campbell WI, Kendrick R, Patterson C. Intravenous diclofenac sodium. Does its administration before operation suppress postoperative pain? Anaesthesia 1990; 45: 763–766.Google Scholar
Rorarius MG, Baer GA, Metsa-Ketela T, Miralles J, Palomaki E, Vapaatalo H. Effects of peri-operatively administered diclofenac and indomethacin on blood loss, bleeding time and plasma prostanoids in man. Eur J Anaesthesiol 1989; 6: 335–342.Google Scholar
Schafer AI. Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol 1995; 35: 209–219.Google Scholar
Michot F, Ajdacic K, Glaus L. A double-blind clinical trial to determine if an interaction exists between diclofenac sodium and the oral anticoagulant acenocoumarol (nicoumalone). J Int Med Res 1975; 3: 153–157.Google Scholar
Pardo A, Garcia Losa M, Fernandez Pavon A, et al. A placebo-controlled study of interaction between nabumetone and acenocoumarol. Br J Clin Pharmacol 1999; 47: 441–444.Google Scholar
McKenna F. COX-2: separating myth from reality. Scand J Rheumatol Suppl 1999; 109: 19–29.Google Scholar
Vane JR, Botting RM. New insights into the mode of action of anti-inflammatory drugs. Inflamm Res 1995; 44: 1–10.Google Scholar
Meade EA, Smith WL, DeWitt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993; 268: 6610–6614.Google Scholar
de Meijer A, Vollaard H, de Metz M, Verbruggen B, Thomas C, Novakova I. Meloxicam, 15 mg/day, spares platelet function in healthy volunteers. Clin Pharmacol Ther 1999; 66: 425–430.Google Scholar
Stichtenoth DO, Wagner B, Frolich JC. Effects of meloxicam and indomethacin on cyclooxygenase pathways in healthy volunteers. J Investig Med 1997; 45: 44–49.Google Scholar
Giuliano F, Warner TD. Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs. Br J Pharmacol 1999; 126: 1824–1830.Google Scholar
Perttunen K, Kalso E, Heinonen J, Salo J. IV diclofenac in post-thoracotomy pain. Br J Anaesth 1992; 68: 474–480.Google Scholar
Power I, Chambers WA, Greer IA, Ramage D, Simon E. Platelet function after intramuscular diclofenac. Anaesthesia 1990; 45: 916–919.Google Scholar